An adequate balance between serine proteases and their plasminogen activator inhibitor-1 (PAI-1) is critical for pathological angiogenesis. PAI-1 deficiency in mice is associated with impaired choroidal neovascularization (CNV) and tumoral angiogenesis. In the present work, we demonstrate unexpected differences in the contribution of bone marrow (BM)-derived cells in these two processes regulated by PAI-1. PAI-1 ؊/؊ mice grafted with BM-derived from wild-type mice were able to support laser-induced CNV formation but not skin carcinoma vascularization. Engraftment of irradiated wildtype mice with PAI-1 ؊/؊ BM prevented CNV formation, demonstrating the crucial role of PAI-1 delivered by BM-derived cells. In contrast, the transient infiltration of tumor transplants by local PAI-1-producing host cells rather than by BM cells was sufficient to rescue tumor growth and angiogenesis in PAI-1-deficient mice. These data identify PAI-1 as a molecular determinant of a local permissive soil for tumor angiogenesis. Altogether, the present study demonstrates that different cellular mechanisms contribute to PAI-1-regulated tumoral and CNV. PAI-1 contributes to BM-dependent choroidal vascularization and to BM-independent tumor growth and angiogenesis. (Am J Pathol 2007, 171:000 -000;
Plasminogen activator inhibitor type 1 (PAI-1) is a key regulator of the plasminogen activator (PA)-plasmin system, a proteolytic cascade implicated in various physiological and pathological processes including vascular thrombolysis, inflammation, wound healing, choroidal neovascularization (CNV) associated with age-related macular degeneration and cancer progression. PAI-1 is the main physiological inhibitor of urokinase-type plasminogen activator (uPA) and tissue-type plasminogen activator (tPA), two serine proteases that both convert the inactive zymogen plasminogen into active plasmin.
1,2 By its capacity to degrade a variety of matrix components and to activate matrix metalloproteinases (MMPs) as well as growth factors, plasmin is a key regulator of various physiological and pathological processes associated with pericellular remodeling. In clinical studies, elevated PAI-1 levels have been correlated with various chorioretinal pathologies 3, 4 and are predictive of poor survival for patients suffering from different types of cancer. 5, 6 By applying different experimental models into PAI-1-deficient mice (PAI-1 Ϫ/Ϫ mice), a crucial role has been demonstrated for PAI-1 in tumor growth and angiogenesis, [7] [8] [9] as well as in CNV, 10 which is the hallmark of the most severe form of age-related macular degeneration and the major cause of blindness in people 50 years of age or more. The formation of tumor and/or choroidal neovessels may involve different mechanisms including at least angiogenesis, endothelial cell sprouting from pre-existing Supported by the Communauté Franç aise de Belgique (Actions de Recherches Concerté es), the Commission of European Communities (FP6), the Fonds de la Recherche Scientifique Mé dicale, the Fonds National de la Recherche Scientifique (Belgium; to M.J., C.M., J.L., and K.B.), the Fédé ration Belge Contre le Cancer, the Fonds Spé ciaux de la Recherche (University of Liè ge), Les Amis des Aveugles (Ghlin, Belgium), the Centre Anticancé reux prè s l'Université de Liè ge, the FB Assurances, the Fondation Lé on Frédé ricq (University of Liè ge), the Direction Géné rale des Technologies, de la Recherche et de l'Energie from the "Ré gion Wallonne," and the Interuniversity Attraction Poles Programe-Belgian Science Policy (Brussels, Belgium). vessels, and vasculogenesis, recruitment of circulating endothelial progenitor cells into blood vessels. [11] [12] [13] [14] The contribution of BM-derived cells in PAI-1-regulated pathological neovascularization (laser-induced CNV and skin tumor cell transplantation) remains to be determined. PAI-1 can be produced by different cell types such as inflammatory cells (macrophages, mast cells), smooth muscle cells, endothelial cells, and (myo)fibroblasts. The biological relevance of host cells producing PAI-1 during cancer growth and invasion has been demonstrated in the model of malignant keratinocyte transplantation. 7, 8, 15 In this system, although the malignant PDVA cells used are able to produce PAI-1, the deficiency of PAI-1 in mice prevented tumor vascularization and invasion. 7 Interestingly, although the overexpression of PAI-1 by tumor cells cannot compensate for host PAI-1 deficiency, 16 induction of PAI-1 expression in host tissue by using adenoviral vector restored tumor growth and vascularization. 7 In the present study, we aimed at elucidating and comparing the putative role of BM-derived cells during tumor and CNV formation. Two experimental models (malignant keratinocytes transplantation and laser-induced CNV) were applied to WT (PAI-1 ϩ/ϩ ) and PAI-1 Ϫ/Ϫ mice previously irradiated and grafted with WT BM cells. We provide evidence that transplantation of wild-type (WT) BM cells into irradiated PAI-1 Ϫ/Ϫ mice was sufficient to rescue CNV but failed to restore tumor angiogenesis. In contrast to what occurs in CNV formation, in the tumor transplantation system, resident host cells rather than BM-derived cells significantly contribute to the angiogenic process. These data demonstrate for the first time that PAI-1 controls BM-dependent vascularization in ocular disease and BM-independent angiogenesis in skin tumors.
Materials and Methods

Transgenic Mice
Homozygous PAI-1-deficient mice (PAI-1 Ϫ/Ϫ ) and their corresponding WT mice with a mixed genetic background of 87% C57BL/6 and 13% 129SV/SL strain were used. 7, 8, 10 The corresponding immunodeficient mice were generated in a Rag-1 Ϫ/Ϫ background (PAI-1
. 17 Transgenic mice heterozygous for the enhanced green fluorescent protein (eGFP) under the control of ␤-actin promoter C57BL/6-Tg(ACTbEGFP)10sb were obtained from the Jackson Laboratories (Bar Harbor, ME). Mouse experimentation was done in accordance to the guidelines of the University of Liè ge regarding the care and use of laboratory animals.
Bone Marrow (BM) Transplantation
BM cells were isolated from the tibia and femur of donor mice, 8 to 10 weeks of age, by slowly flushing RPMI 1640 culture medium (Gibco BRL, Paisley, UK) inside the diaphyseal channel. Recipient mice (8 to 10 weeks old) sublethally irradiated with a single dose of 4 Gy were injected intravenously with BM cells (10 7 per animal). At 5 weeks after BM transplantation, malignant keratinocytes were transplanted or impact laser burns were performed.
Keratinocyte Transplantation Model
Malignant murine keratinocytes (PDVA cells) were generated from B10LP mice after a carcinogen treatment (dimethylarsinic acid). Tumor cells (2 ϫ 10 5 ) cultured on a collagen gel inserted in Teflon rings (Renner GmbH, Dannstadt, Germany) were covered with a silicone transplantation chamber (Renner GmbH) and implanted in toto onto the dorsal muscle fascia of PAI-1 Ϫ/Ϫ and PAI-1 ϩ/ϩ mice as previously described. 7, 16, 17 Three weeks later, transplants were resected, embedded in Tissue Tek (Miles Laboratories, Inc., Naperville, IL), and frozen in liquid nitrogen for cryostat sectioning. 8, 17 In some assays, transplantation chambers were implanted for 1 week in PAI-1 Ϫ/Ϫ or PAI-1 ϩ/ϩ mice. At day 7, mice were sacrificed, and the whole chambers were harvested with caution, rinsed in PBS, and transferred into new immunodeficient recipient mice (Rag-1
. 17 The chambers were left for 3 additional weeks before harvesting for histological analysis.
Scoring of Tumor Vascularization
Tumor vascularization was scored as follows: 0, vessels undetected in the collagen gel; ϩ, vessels infiltrating the collagen gel; and ϩϩ, blood vessels intermingled with invasive epithelial tumor sprouts. Tumors scored ϩ or ϩϩ were considered as angiogenic tumors.
CNV Model
CNV was induced in both eyes of mice by laser burns as previously described.
10 After 14 days (or earlier time points in kinetic analysis), animals were sacrificed, and both eyes were enucleated (n ϭ 4 to 8 animals per experimental condition with four lesions per eye, ie, eight lesions per animal). For immunohistochemical analysis, eyes were embedded in Tissue Tek for cryostat sectioning. Neovascularization was estimated by computer-assisted measurement on at least five sections per lesion of the B-C/C ratio (B, thickness from the bottom of the pigmented choroidal layer to the top of the neovascular membrane; C, thickness of the intact pigmented choroid adjacent to the lesion).
For confocal visualization of the vasculature, mice were injected intravenously with 200 l of tetramethylrhodamine isothiocyanate (TRITC)-conjugated dextran (160 kd average molecular weight; Sigma, St. Louis, MO) or fluorescein isothiocyanate (FITC)-conjugated dextran (2 ϫ 10 3 kd average molecular weight, Sigma) (50 mg/ ml). After 1 hour of fixation in paraformaldehyde 1% (pH 7.4), retinas were removed, and choroids were flatmounted using Vectashield mounting medium (Vector Laboratories, Burlingame, CA). Spatial distribution of fluorescence was examined using a Leica TCS SP2 inverted confocal laser microscope (Leica Microsystems, Wetzlar, Germany) equipped with an argon and two helium-neon lasers and an acousto-optical tunable filter for excitation intensity. Digitized images were acquired using a 10ϫ (NA 0.4) or 63ϫ (NA 1.5) Plan-Apo waterimmersion objective at 1024 ϫ 1024-pixel resolution. For multicolor imaging, GFP was visualized by using an excitation wavelength of 488 nm, and the emission light was dispersed and recorded at 500 to 535 nm. TRITC was detected by using an excitation wavelength of 543 and the 488/543-nm dichroic mirror, and the fluorescence emission was dispersed and recorded at 590 to 700 nm. For each lesion, serial optical sections were recorded with a z-step of 1.67 m. After successive scanning for each interval, the three-dimensional fluorescent images were constructed by using Leica confocal software. The volume of CNV on choroidal flatmount was determined as previously described. 18 
Immunohistochemistry
Cryostat sections (6 m in thickness) were fixed in acetone at Ϫ20°C and in methanol 80% at 4°C before incubation with primary antibodies (Abs). For double-immunofluorescent-labeling studies, sections were incubated with two primary Abs. Antibodies raised against type IV collagen (rabbit polyclonal Ab, diluted 1/100; produced in our laboratory), keratin (guinea pig polyclonal Ab, diluted 1/20; Sigma), neutrophils (rat anti-mouse, diluted 1/200; Serotec, Oxford, UK), NG2 chondroitin sulfate proteoglycan (pericytes, rabbit anti-rat, diluted 1/200; Chemicon, Temecula, CA), CD11b/TRITC (rat antimouse, diluted 1/50; Pharmingen, San Diego, CA), ␣-smooth muscle actin/FITC (mouse monoclonal, diluted 1/200; Sigma-Aldrich), ␣-smooth muscle actin/Cy3 (mouse monoclonal, diluted 1/1000; Sigma-Aldrich) were incubated for 1 hour at room temperature. After washings, the appropriate secondary antibodies conjugated to FITC and Texas Red were applied, swine anti-rabbit (diluted 1/40; Dakopat, Glostrup, Denmark), mouse antiguinea pig (diluted 1/40; Sigma), and goat anti-rat (diluted 1/100; Molecular Probes, Eugene, OR), for 30 minutes.
For immunolabeling revealed with AEC systems, the sections were incubated for 1 hour at room temperature with primary Ab, PECAM (rat anti-mouse, diluted 1/250; Pharmingen), neutrophils (rat anti-mouse, diluted 1/200; Serotec), and F4/80 macrophages (rat anti-mouse, diluted 1/300; Serotec), and then incubated with secondary Ab rabbit anti-rat/biotin (diluted 1/400; DAKO, Glostrup, Denmark). The revelation was performed with AEC staining after the incubation of streptavidin/horseradish peroxidase (diluted 1/500; DAKO) for 30 minutes.
For quantitative measurement of host cell infiltration in the collagen gel, automatic computer-assisted image analysis was performed on images obtained after bisbenzimide staining and immunolabeling of inflammatory cells or mesenchymal cells. The ratio between the surface of bisbenzimide staining and the surface of specific immunostaining was measured by using Aphelion 3.2 software (Adsis, Meythet, France).
In Situ Hybridization Analysis: Y-Chromosome Detection
Smears of BM and peripheral blood were fixed with acetone for 10 minutes at 4°C, with Carnoy's fixative (3:1, methanol/acetic acid) at 4°C for 10 minutes, washed, and fixed in formaldehyde 1% at 4°C for 1 minute. The slides were dehydrated, denatured in 70% formamide/2ϫ standard saline citrate buffer at 72°C for 5 minutes, quenched in ice-cold 70% ethanol, and air-dried. The FITC Y-painting chromosome probes (Cambio, Cambridge, UK) were denatured at 65°C for 10 minutes, incubated for 30 minutes at 37°C hybridization, and were added on each slide for overnight incubation at 37°C. Slides were washed in 2ϫ standard saline citrate/0.3% Tween 20, first at 72°C and then at room temperature. After dehydration, slides were mounted with Vectashield medium containing propidium iodide (Vector Laboratories, Peterborough, UK).
Colony-Forming Unit Assay: CFU-Cs
Total BM cells (2 ϫ 10 4 cells) and blood cells (2 ϫ 10 5 cells) were plated in 35-mm suspension culture dishes containing 1.1 ml of 1% methylcellulose [Methocult (StemCell Technologies) containing 15% fetal bovine serum, 1% bovine serum albumin, 10 g/ml human insulin, 200 g/ml human transferrin, 10 Ϫ4 mol/L 2-mercaptoethanol, 2 mmol/L L-glutamine, 50 ng/ml mouse stem cell factor, 10 ng/ml mouse interleukin (IL)-3, 10 ng/ml human IL-6, and 3 U/ml human erythropoietin]. Scoring of CFU-C (CFU-GM, BFU-E, and CFU-Mix) was performed on day 10 with an inverted microscope.
Transmission Electron Microscopy
Transplants were fixed in 2.5% glutaraldehyde-0.15 mol/L cacodylate buffer, postfixed in 2% aqueous osmium tetroxide, dehydrated in a graded series of ethanol, and embedded in Epon. Transplants were sectioned perpendicular to the gel surface. Ultrathin sections were contrasted with uranyl acetate and lead citrate before examination with a Jeol (Tokyo, Japan) CX100 electron microscope at 60 kV.
Statistical Analysis
Data were analyzed with GraphPad Prism 4.0 (San Diego, CA). The Mann-Whitney test or 2 test were used to determine whether differences between experimental groups could be considered as significant (P Ͻ 0.05).
Results
BM Transplantation
WT (PAI-1 ϩ/ϩ ) and PAI-1-deficient (PAI-1 Ϫ/Ϫ ) mice were irradiated and transplanted with unfractionated WT or PAI-1 Ϫ/Ϫ BM. Five weeks after BM transplantation (ie, after allowing for BM reconstitution), laser burns were performed to induce CNV, or malignant keratinocytes were transplanted. Genotyping of spleen and liver was performed for all animals. In addition, success of BM transplantation was assessed by two different approaches. First, BM from GFP transgenic mice was transplanted into irradiated WT or PAI-1 Ϫ/Ϫ mice, and flow cytometry was performed on peripheral blood and BM. Second, irradiated female animals (WT or PAI-1 Ϫ/Ϫ ) were transplanted with BM harvested from tibia and femur of male mice (WT or PAI-1 Ϫ/Ϫ ). BM-derived male cells were detected in BM and blood by using in situ hybridization for Y-chromosome DNA. A similar percentage of BM reconstitution (70 to 80%) was observed with these two approaches. Interestingly, the lack of PAI-1 in either the recipient or the donor cells did not affect the proportion of BM reconstitution. In addition, functionality of BM-derived stem cells was identical in different groups of mice engrafted or not as assessed by colony-forming unit assay (data not shown).
CNV
Photocoagulation with an argon laser induced trauma leading to CNV under retina similar to that observed in agerelated macular degeneration. Damage and neovascularization were estimated by measuring, on serial sections, the maximal height of lesion (B) above the thickness of the normal choroid observed in neighboring intact zones (C). Two weeks after laser burns, WT mice showed typical mushroom-like areas of CNV characterized by a B-C/C ratio of 1.544 Ϯ 0.076. In PAI-1 Ϫ/Ϫ mice the neovascular reaction was much more restricted with a B-C/C ratio of 1.057 Ϯ 0.056 (P Ͻ 0.001) ( (Figure 1 ). These inflammatory cells were no longer detected at day 14. Therefore, these data clearly demonstrate the recruitment of inflammatory cells and endothelial cells in laser-induced choroidal lesions.
We next investigated whether the transplantation of PAI-1 ϩ/ϩ BM could restore the impaired CNV observed in mutated mice. The BM of irradiated PAI-1 Ϫ/Ϫ mice were reconstituted with BM extracted from PAI-1 ϩ/ϩ mice (n ϭ 8, ie, 64 lesions) or PAI-1 Ϫ/Ϫ mice (n ϭ 8, ie, 64 lesions) as a control, and mice were subjected to laser. CNV was quantified by measuring different parameters: (B-C)/C ratio determined on tissue section ( Figure 2A ) and volume of CNV on choroidal flatmounts ( Figure 2B ) observed by confocal microscopy. 19 A complete restoration of neovascularization was observed in PAI-1 Ϫ/Ϫ mice engrafted with WT ( Figure 2) . In sharp contrast, choroidal lesion was smaller in PAI-1 Ϫ/Ϫ mice transplanted with PAI-1 Ϫ/Ϫ BM (P Ͻ 0.005) and similar to that observed in control PAI-1 Ϫ/Ϫ mice ( Figure 2) . Interestingly, the engraftment of PAI-1-deficient BM into WT mice decreases significantly the CNV in comparison to WT control mice (n ϭ 4, ie, 32 lesions) (P Ͻ 0.005) (Figure 2 ).
To visualize spatial and temporal distribution of BMderived cells in laser-induced lesions, BM from GFP transgenic mice was engrafted into control C57BL/6 WT mice (n ϭ 4), PAI-1 ϩ/ϩ (n ϭ 8), and PAI-1 Ϫ/Ϫ (n ϭ 8) mice. At different time points after laser injury, flatmount preparations of eyes were analyzed by confocal microscopy ( Figure 3, A-F ). Vessels were concomitantly visualized in red by injecting dextran-TRITC. GFP ϩ cells were visualized in all lesions and were never detected in the neighboring intact chorioretinal areas. At day 3, isolated cells positive for GFP were abundant in CNV lesions, in contrast to normal unlesioned choroids ( Figure 3A ). This cell recruitment precedes the neoformation of vessel since at this time point, no vessel structure was identified by dextran-TRITC injection. At days 5 and 7, both isolated cells and vessel-associated cells were GFP labeled (Figure 3, B and C) . A substantial proportion of GFP-positive cells was not directly associated to vessel structures (75.30%, range 60 to 82%). Some GFP ϩ cells closely apposed to and covered neovessels ( Figure 3, E and F) . Occasionally, GFP-positive cells were found incorporated into newly formed vessels ( Figure 3E ). Immunohistochemical staining of choroidal lesion revealed that GFP-positive cells were not associated with ␣-smooth muscle actin labeling ( Figure 3G ). In contrast, GFP positivity co-localized with CD11b staining, identifying BMderived cells as inflammatory cells ( Figure 3H ). Similar recruitment and localization of BM-derived cells were observed in both PAI-1 ϩ/ϩ and PAI-1 Ϫ/Ϫ mice. These results demonstrate that BM-derived cells are sufficient to restore the vascularization impaired by PAI-1 deficiency. Ϫ/Ϫ mice (e). The B-C/C ratio was determined by computer-assisted image analysis as described in Materials and Methods (see also legend of Figure 1 ). Number of animals per experimental group: n ϭ 8 with four impacts per eye, ie, 64 lesions. *P Ͻ 0.05; ***P Ͻ 0.005 compared with control PAI-1 ϩ/ϩ mice (d).
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Malignant Keratinocyte Transplantation
To determine whether BM-derived cells could restore the impaired vascularization observed in the absence of PAI-1, in other pathological conditions, we have used a model of skin tumor transplantation as previously described. 7, 8, 16 Mouse malignant PDVA keratinocytes precultured on a collagen type I gel were covered by a silicone chamber and transplanted in toto onto the back muscle fascia of mice. 15 The grafted cells rapidly devel- oped into highly proliferating stratified epithelia, and collagen gel was gradually replaced by a highly vascularized granulation tissue. Three weeks after transplantation, new blood vessels invaded the collagen gel in PAI-1 ϩ/ϩ mice, reached malignant epithelial layer and were associated to stromal septa of invading tumors ( Figure  4D ). In sharp contrast, blood vessels failed to migrate in PAI-1 Ϫ/Ϫ mice and remain in host tissue, below the collagen gel ( Figure 4E ). 7 To better identify host cells involved in such invasive and angiogenic process, we performed a histological analysis of tumor samples at 1 week and 3 weeks after tumor transplantation (Figure 4) . At each time point (n ϭ 10), we observed an infiltration of inflammatory cells stained with antibodies recognizing myelomonocytic cells (anti-CD11b) (Figure 4, F Because inflammatory cells and endothelial cells seemed to be the major types of infiltrating cells, BM engraftment was performed to determine the origin of critical cells whose lack of PAI-1 led to impaired vascularization and invasion. When malignant keratinocytes were transplanted into PAI-1 Ϫ/Ϫ mice engrafted with PAI-1 ϩ/ϩ BM, none of the animals developed vascularized tumors (score 0 in 100% mice, n ϭ 10) ( Figure 5B) . Thus, the angiogenic and invasive phenotypes were similar to those observed in control PAI-1 Ϫ/Ϫ mice ( Figure 4E ) or in PAI-1 Ϫ/Ϫ mice engrafted with PAI-1 Ϫ/Ϫ BM ( Figure 5C ) and distinct to that of PAI-1 ϩ/ϩ mice ( Figure 5A ). The presence of functional engrafted PAI-1 ϩ/ϩ BM cells in the grafted mice was assessed by the presence of PAI-1-positive cells in their spleen (data not shown). In contrast, the engraftment of PAI-1 Ϫ/Ϫ BM in PAI-1 ϩ/ϩ mice did not affect the vascularization observed usually in WT mice ( Figure 5D ). The recruitment of BM-derived cells in tumors was next investigated by grafting C57BL/6 WT mice with BM from GFP transgenic mice. Few GFP ϩ cells were visualized in the tumor transplants, but their detection was restricted to the tumor-host interface ( Figure 5E ).
These data suggest that, in contrast to CNV, BM cells are not sufficient to restore impaired tumor vascularization and invasion in the transplantation system. The importance of local host cells infiltrating the collagen gel was then investigated by transferring tumor transplants from PAI-1 ϩ/ϩ mice to PAI-1 Ϫ/Ϫ mice ( Figure 6 ). PDVA cells precultured on a collagen gel were transplanted into PAI-1 ϩ/ϩ or to PAI-1 Ϫ/Ϫ mice. One week later, tumor transplants were harvested and transferred into PAI-1 ϩ/ϩ or to PAI-1 Ϫ/Ϫ mice, and tumors were led to grow for 3 additional weeks. As controls, PDVA cells were transplanted for 3 consecutive weeks into PAI-1 ϩ/ϩ or to PAI-1 Ϫ/Ϫ mice. An invasive and angiogenic phenotype (scores ϩ or ϩϩ) was observed in 100% of tumors transplanted for 3 consecutive weeks into PAI-1 ϩ/ϩ mice ( Figure 6e ) and in 80% of tumors transplanted for 1 week into PAI-1 ϩ/ϩ mice and then transferred for 3 weeks in PAI-1 ϩ/ϩ mice ( Figure 6d ) (n ϭ 5). None of the tumors were invasive or vascularized (score 0 in 100% animals) after transplantation into PAI-1 Ϫ/Ϫ mice for 3 weeks (Figure 6a) 
Discussion
PAI-1-deficient mice cannot support neovascularization when challenged with malignant keratinocytes or laserinduced choroidal lesions. 8, 10 We provide for the first time evidence that two distinct processes of pathological neovascularization controlled by PAI-1 involve different responses of BM-derived cells to angiogenic stimuli. Key contribution of BM-derived cells in CNV is demonstrated by the impaired vascularization in WT mice grafted with PAI-1 Ϫ/Ϫ BM and the rescue of CNV pattern in deficient mice by WT BM-derived cells. We have previously reported that CNV formation in PAI-1-deficient mice can be restored when systemic and local PAI-1 expression was achieved by injection of recombinant protein 20 or replication-defective adenovirus bearing human PAI-1 cDNA. 10 The present data indicate that BM-derived cells can deliver PAI-1 to choroidal lesions. Conversely, the crucial involvement of host cells distinct from BM cells in skin carcinomas is supported by the restoration of tumor invasion and vascularization after transfer of tumor transplants from PAI-1 ϩ/ϩ mice to PAI-1 Ϫ/Ϫ mice, whereas BM transplantation failed to circumvent the angiogenic defect observed in mutant mice. To the best of our knowledge, this report provides first experiment evidence for a key role played by BM-derived PAI-1 in pathological ocular vascularization. In addition, it identifies PAI-1 as an important molecular determinant of the seed and soil theory proposed by Paget. eral groups, 18, 22, 23 thus offering new potential targets for the development of anti-angiogenesic therapies. In addition, we demonstrate, for the first time, that BM-derived cells producing PAI-1 are essential actors of CNV formation. In support of this new concept is the evidence that CNV formation was impaired in WT mice grafted with PAI-1 Ϫ/Ϫ BM. Of great interest is also our finding that WT BM-derived cells can rescue the defective CNV pattern observed in PAI-1-deficient mice. These data demonstrate that CNV formation was dependent to the PAI-1 status of BM-derived cells and not to that of resident endothelial cells. The incapacity of BM-derived cells issued from PAI-1 Ϫ/Ϫ mice to rescue impaired vascularization could not be ascribed to a defect of BM reconstitution as assessed by detection of male (Y-chromosome DNA-positive) donor cells in female recipient mice as well as by functional CFU-C assay.
The main proportion of BM-derived cells was not incorporated into vessel structure and importantly was recruited at early phases of CNV formation before detection of any vessel (at day 3). Immunohistochemical analysis revealed the presence of neutrophils and macrophages from days 3 to 7. GFP positivity co-localized with CD11b staining. The present study does not strongly support the recruitment of BM-derived cells into CNV. It provides evidence that BM-derived cells are active players of CNV mainly by contributing to the inflammatory response rather than by providing endothelial cell progenitor. These observations are consistent with the demonstration that in a mouse model of hindlimb ischemia (arteriogenesis and angiogenesis), BM-derived cells do not promote vascular growth by incorporating into vessel walls but may function as supporting cells. 24 In sharp contrast, in our tumor transplant model, BMderived cells could be mobilized at the tumor-host interface but did not compensate for the inability of neighboring PAI-1-deficient endothelial cells to form new vessels and did not incorporate into tumor vasculature. Although BM-derived cells can contribute to tumor neoangiogenesis in several experimental models, 12, 25 their contribution does not seem universal. 26 -29 For instance, BM cells did not appreciably contribute to the vasculature of murine gliomas 30 and stem cells have been reported to contribute to human tumor endothelium at low levels averaging only 4.9%. 31 Altogether, these data suggest that the contribution of BM precursors to tumor vessel formation may be dependent on the steps of tumor progression and on the tumor types. 24, 32, 33 Tumor angiogenesis and invasion involve complex interactions occurring between tumor cells and different host cell types, such as endothelial cells, inflammatory cells, and fibroblasts. Most inflammatory cells (macrophages, monocytes, neutrophils, mast cells) produce proteases and secrete cytokines, chemokines, and growth factors essential for extracellular matrix remodeling, cell migration, and angiogenesis. 34, 35 The detection of only few cells derived from the BM of GFP transgenic mice in tumor transplants indicates that local vascular cells contribute more to tumor progression than BM-derived cells, in this model of skin carcinoma. Our data PAI-1 in BM Angiogenesis 9 AJP October 2007, Vol. 171, No. 4 demonstrate that the infiltration of transplanted matrix by PAI-1-producing host cells during the first week of transplantation is sufficient to rescue tumor invasion and vascularization after transfer into PAI-1 Ϫ/Ϫ mice. Thus, local host cells infiltrating the collagen gel during the early phase of tumor transplantation are essential for tissue remodeling and to create a permissive soil for tumor invasion and vascularization. During tumor growth, stromal activation is an early event with rapid progression of blood vessels and stromal cells toward the tumor layer. This host reaction precedes tumor cell invasion into the surrounding tissue. 36 Therefore, the skin malignant keratinocyte layer observed in PAI-1 Ϫ/Ϫ mice could not be ascribed to differential rejection of tumor transplant 8, 17, 36 but rather reflects an impaired stromal reaction and vascularization in the absence of PAI-1, a prerequisite for tumor invasion. 36, 37 The present study identifies PAI-1 as a molecular determinant of the seed and soil hypothesis of Paget. Ϫ/Ϫ mice, whereas inflammatory cell recruitment was identical in both genotypes. An intriguing possibility to consider in our tumor model is the cooperation between inflammatory cells and resident host cells (endothelial cells and/or fibroblasts). In this context by using this tumor transplantation model, we have previously demonstrated the key role played by two gelatinases, MMP-2 produced by mesenchymal cells and MMP-9 secreted by neutrophils. 38 Indeed, although the single deficiency of MMP-2 or MMP-9 did not affect tumor cell invasion and vascularization, their combined deficiency abolished the invasive and angiogenic phenotype of malignant keratinocytes.
Our previous studies have emphasized similarities between the molecular mechanisms of PAI-1 action in CNV and tumor vascularization. A dose-dependent effect of PAI-1 has been evidenced, PAI-1 being proangiogenic at low concentrations and anti-angiogenic at supraphysiological doses. 16, 20 PAI-1 is known to control uPA-dependent plasmin generation, and therefore it may control extracellular matrix degradation and growth factor and/or cytokine/chemokine activation. In addition, PAI-1 can interfere with integrin binding to tissue vitronectin, thereby influencing cell migration. 39, 40 By using recombinant proteins and/or adenoviral-mediated transfer of mutated forms of PAI-1, we clearly demonstrated previously that the contribution of PAI-1, in both pathological processes, is related to its capacity to control plasmin-mediated proteolysis rather than by interacting with vitronectin. 8, 20 Analysis of endothelial cell sprouting from PAI-1 Ϫ/Ϫ aortic fragments corroborated this molecular mechanism of PAI-1 action. 41 Although extracellular proteolysis is required for cell migration, an excess of proteolysis would impair the presence of a permissive substrate for cell migration. Through its capacity to control plasmin-mediated proteolysis, PAI-1 may tightly control proteolytic events associated with cell migration. 16, 20, 41 Both a defect and an excess of PAI-1 levels led to impaired vascularization of laser-induced choroidal lesions 20 and of tumor transplants. 16 It is worth noting that recent reports demonstrate the requirement of proteolytic enzyme such as cathepsin L 42 and uPA 43 for the migration of BMderived cells such as endothelial progenitor cell. The function of PAI-1 could therefore consist in the protection of migrating cells by preventing excessive pericellular proteolysis and/or cellular damage. Despite molecular similarities, between the two PAI-1-controlled vascularization processes, the present study demonstrates for the first time that different cellular mechanisms contribute to PAI-1-regulated neovascularization in these two models. Our study sheds new lights on what role individual PAI-1-producing cells play in the pathogenesis of CNV and cancer.
In conclusion, the two processes of pathological vascularization studied here are both dependent to PAI-1 levels. The present study indicates that BM-derived cells are essential to deliver PAI-1 to CNV, but not to skin transplanted carcinomas. It gives new insight into the respective roles of circulating and resident cells in PAI-1-controlled vascularization. By revealing the essential role of BM-derived cells in CNV, it opens new opportunities for the selection of genetic therapeutic strategies targeting BM cells for CNV prevention or inhibition. 
